Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 300.00% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -6.36% vs 41.75% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -13.46% vs 36.59% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -100.00% vs -70.21% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Immunovia AB With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 300.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 300.00% vs -50.00% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -6.36% vs 41.75% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 68.17% vs -1,893.10% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -13.46% vs 36.59% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -2.91% vs 20.37% in Mar 2025
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






